HHS Secretary RFK Jr. appeared on Capitol Hill for two hearings on Wednesday.
RFK Jr. first testified before the Senate Finance Committee on his agency’s budget and the deals that the Trump Administration struck with drug companies to lower prices.
Democrat Senator Elizabeth Warren tried to go after RFK Jr. over TrumpRx’s price cuts, but he shut her down.
In February, President Trump launched ‘TrumpRx’ to lower drug prices.
“Today, President Donald J. Trump announced the launch of TrumpRx.gov. Through the website, patients will be able to access large discounts on many of the most popular and highest-priced medicines in the country, paying prices in line with the lowest paid by other developed nations (known as the most-favored-nation, or MFN, price),” the White House announced in February.
“Today’s launch features drugs made by the first five manufacturers to reach MFN pricing deals with the Trump Administration: AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk, and Pfizer,” the White House said.
“Additional drugs from other companies that have signed MFN pricing deals will be made available through TrumpRx.gov in the coming months,” they said.
TrumpRx lowers prices for popular weight loss drugs such as Ozempic and Wegovy, inhalers, fertility drugs, and insulin.
Elizabeth Warren, a corrupt and worthless Democrat who has spent decades enriching herself by lying about being a Native American, tried to come at RFK Jr. about TrumpRx.
“If these pharma deals are so good, show them!” Warren said to RFK Jr.
“You had the power to make this deal yourself! Why didn’t you do that? We did this because you refuse to do it!” RFK Jr. said.
“You have a lot more power to negotiate than we do! We got the lowest prices in history,” he said.
Elizabeth Warren hit back and claimed TrumpRx is making things worse for the American people.
“Millions of people who are using Trump Rx disagree with you!” RFK Jr. said.
WATCH:
The post RFK Jr. Torches Democrat Senator Elizabeth Warren During Hearing on TrumpRx Drug Price Cuts (VIDEO) appeared first on The Gateway Pundit.